Kidney Transplant Noninferior From Donors With Versus Without HIV in HIV-Positive Recipients
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 17, 2024 -- Among recipients with HIV, kidney transplantation from donors with HIV is noninferior to that from donors without HIV, according to a study published online Oct. 16 in the New England Journal of Medicine.
Christine M. Durand, M.D., from Johns Hopkins University School of Medicine in Baltimore, and colleagues compared transplantation of kidneys from deceased donors with and without HIV to recipients with HIV. The primary outcome was a safety event (composite of death from any cause, graft loss, serious adverse events, HIV breakthrough event, persistent failure of HIV treatment, or opportunistic infection), assessed for noninferiority.
The researchers enrolled 408 transplantation candidates: 198 received a kidney from a deceased donor, including 99 from a donor with and 99 from a donor without HIV. The adjusted hazard ratio for the composite primary outcome was 1.00 (95 percent confidence interval, 0.73 to 1.38), which demonstrated noninferiority. Overall survival at one and three years, survival without graft loss at one and three years, and rejection at one and three years were similar whether or not the donor had HIV. The groups had a similar incidence of serious adverse events, infections, surgical or vascular complications, and cancer. Recipients of kidneys from donors with HIV had an increased incidence of HIV breakthrough infection (incidence rate ratio, 3.14).
"This multicenter, observational study showed that kidney transplantation from donors with HIV to recipients with HIV is noninferior to kidney transplantation from donors without HIV to recipients with HIV," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-18 06:00
Read more
- Clinicians Often Fail to Rescue Women With Complications After High-Risk Surgery
- Why Treatments Can Fail Folks With 'Wet' Macular Degeneration -- and What Might Really Work
- Short-Term Hormone Therapy for Menopause Won't Harm Women's Brains
- Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
- COVID-19 Mortality Higher for Leukemia, Myelodysplastic Syndrome Patients
- Human Cell Atlas Will Be 'Google Maps' for Health Research
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions